Work

Bortezomib induction prior to autologous hematopoietic cell transplantation (AHCT) for newly diagnosed light chain amyloidosis (AL): A study of 426 patients.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.8515

Authors: Robert F. Cornell, Parameswaran Hari, Stacey Goodman, Luciano J. Costa, Raphael Fraser, Noel Estrada-Merly, Shaji Kumar, Muzaffar H. Qazilbash, Anita D'Souza

Institutions: Vanderbilt University Medical Center, Medical College of Wisconsin, University of Alabama at Birmingham, Mayo Clinic, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W3031840027

Cites:

Cited by: 2

Related to: 10